Abril 2026

Protective effect of a second booster dose against long COVID among individuals infected with SARS-CoV-2 in southeastern Brazil

Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines

A 69-year-old woman with dermatopathic lymphadenopathy and hypercalcemia after COVID-19 infection

Association of plasma ferritin and plasma iron at time of vaccination with the immune response to SARS-CoV-2 vaccination

Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19